We also assessed the mRNA level of EYA2 in distinct breast cancer cell types (42), showing that there was no remarkable difference of EYA2 mRNA between luminal-type and basal-like cell lines (p = 0.666) (Supplementary Figure 1B). This evidence concerns the gene EYA2 and breast carcinoma.